🔴 NeOnc Technologies Holdings is trading 8% down today with no clear catalyst identified

NeOnc Technologies Holdings is trading 7.61% down now at $3.02, with no clear, directly supported catalyst identified.

• The company announced plans for a proposed trial targeting approximately 500 patients across 30 hospitals in three countries; this describes planned participation, not completed enrollment.
• Major U.S. indexes were higher in the supplied market context, which does not explain the decline. Available evidence does not establish why shares are falling.